In Cappadocia, Turkey, there are three villages, Karain, Old Sarihidir, and Tuzkoy, where 50% of deaths are? caused by malignant mesothelioma (MM). This incredible epidemic has been linked to exposure to erionite,? a type of zeolite fiber. We have established that genetic predisposition plays an important role in this MM? epidemics. Our preliminary results demonstrate that in these villages, MM occurs prevalently in certain? families and not in others, that'when high-risk MM family members marry into a low risk family, MM appears? in the descendents. This finding indicates that genetics play a determining role in this epidemic. However,? we also found that MM does not appear to develop in high risk family members born and raised outside? these villages. This application is built around the central hypothesis that the epidemic of MM? observed in Karain, Tuzkoy and """"""""Old"""""""" Sarihidir is caused by the interaction of the environmental? carcinogen erionite with genetic predisposition. 'Our hypothesis is that the same gene that is mutated? in these Cappadocian families, is the main target of asbestos -and possibly SV40- carcinogenesis in? sporadic MM in the Western world. We propose to try to identify the gene/s that predispose to MM in? Cappadocia. We also propose to test the hypothesis that the erionite found in these villages has some? unique characteristic that makes it more oncogenic compared to the erionite found in Nevada, Oregon,? California, and in other parts of the world or to the erionite found in other Cappadocian villages with low or? no prevalence of MM. Finally, we will test - in two American MM families we recently identifed - the? hypothesis that the same gene that predispose to MM in Cappadocia, contributes to familial MM in the? Western world. These studies will be facilitated by the interaction of a multidisciplinary team coordinated by? Dr. Carbone, that includes Drs. Baris and Emri (Turkish physicians), Mossman (in vitro mechanistic? studies), Testa (array-CGH), Cox (genetic linkage), Steele and Dogan (mineralogy), Pass (Clinical Core).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA114047-02
Application #
7494079
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
2
Fiscal Year
2007
Total Cost
$577,028
Indirect Cost
Name
University of Hawaii
Department
Type
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Napolitano, A; Pellegrini, L; Dey, A et al. (2016) Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene 35:1996-2002
Nasu, Masaki; Emi, Mitsuru; Pastorino, Sandra et al. (2015) High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol 10:565-76
Bononi, Angela; Napolitano, Andrea; Pass, Harvey I et al. (2015) Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies. Expert Rev Respir Med 9:633-54
Baumann, Francine; Buck, Brenda J; Metcalf, Rodney V et al. (2015) The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada. J Thorac Oncol 10:731-7
Baumann, Francine; Flores, Erin; Napolitano, Andrea et al. (2015) Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis 36:76-81
Baumann, Francine; Buck, Brenda J; Metcalf, Rodney V et al. (2015) Reply to ""No Increased Risk for Mesothelioma in Relation to Natural-Occurring Asbestos in Southern Nevada"". J Thorac Oncol 10:e64-5
Deng, Xu-Bin; Xiao, Li; Wu, Yue et al. (2015) Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy. Int J Cancer 137:481-90
Ou, Sai-Hong Ignatius; Moon, James; Garland, Linda L et al. (2015) SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM). J Thorac Oncol 10:387-91
Yang, H; Pellegrini, L; Napolitano, A et al. (2015) Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death Dis 6:e1786
Menges, Craig W; Kadariya, Yuwaraj; Altomare, Deborah et al. (2014) Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Cancer Res 74:1261-1271

Showing the most recent 10 out of 52 publications